Angiopoietin-Like 4 Is Involved in the Poor Angiogenic Potential of High Glucose-Insulted Bone Marrow Stem Cells

다국어 초록 (Multilingual Abstract)

Background and Objectives: Diabetes is reported to reduce the function or number of progenitor cells. We compared the gene expression patterns of bone marrow-derived mesenchymal stem cells from diabetic (DM-BMCs) and healthy (non-DM-BMCs) rats and suggested Angiopoietin-like 4 (Angptl4) could be a responsible factor for impaired angiogenesis of DM-BMCs.
Subjects and Methods: BMCs were isolated from DM or non-DM rat, and in vitro angiogenesis activity was compared by tube formation assay on Matrigel and complementary deoxyribonucleic acid expression was analyzed by microarray with or without oxytocin treatment.
Human BMCs (hBMCs) were treated with high glucose, and were performed polymerase chain reaction, Western blot, and enzyme-linked immunosorbent assay. Angptl4 plasmid DNA and micro ribonucleic acid-132 (miR-132) were transfected to immortalized hBMCs.
Results: In vitro angiogenesis assay showed the impaired tube formation in DM-BMCs, and slightly recovery by oxytocin treatment. Angptl4, an adipokine, was upregulated in DM-BMCs compared to non-DM-BMCs. Oxytocin treatment reduced Angptl4 in DM-BMCs. In hBMCs, overexpression of Angptl4 attenuated the tube formation. In addition to Angptl4, miR-132 was increased by high glucose treatment.
Collectively, high glucose resulted in impaired tube formation through miR-132 induction and Angptl4 upregulation in BMCs.
Conclusion: Our results show that the angiogenic activity of BMCs is impaired by high glucose stress, which would be mediated by Angptl4 and miR-132.

참고문헌 (Reference)

1 Ma T, "Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi’s sarcoma" 107 : 14363-14368, 2010

2 Orchard TJ, "Type 1 diabetes and coronary artery disease" 29 : 2528-2538, 2006

3 Choe N, "The microRNA miR-132 targets Lrrfip1to block vascular smooth muscle cell proliferation and neointimal hyperplasia" 229 : 348-355, 2013

4 Devalliere J, "Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation" 28 : 908-922, 2014

5 Yang YH, "Suppression of the Raf/MEK/ERK signaling cascade and inhibition of angiogenesis by the carboxyl terminus of angiopoietin-like protein 4" 28 : 835-840, 2008

6 Kim YS, "Restoration of angiogenic capacity of diabetes-insulted mesenchymal stem cells by oxytocin" 14 : 38-, 2013

7 Rivard A, "Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF" 154 : 355-363, 1999

8 Westenskow PD, "Ras pathway inhibition prevents neovascularization by repressing endothelial cell sprouting" 123 : 4900-4908, 2013

9 Miyahara Y, "Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction" 12 : 459-465, 2006

10 Anand S, "MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis" 16 : 909-914, 2010

11 Ito Y, "Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4" 63 : 6651-6657, 2003

12 Dernbach E, "Impaired interaction of platelets with endothelial progenitor cells in patients with cardiovascular risk factors" 103 : 572-581, 2008

13 Cull CA, "Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78" 116 : 2119-2126, 2007

14 Roger VL, "Heart disease and stroke statistics--2011 update: a report from the American Heart Association" 123 : e18-e209, 2011

15 Loomans CJ, "Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes" 53 : 195-199, 2004

16 Fadini GP, "Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats" 49 : 3075-3084, 2006

17 Grundy SM, "Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association" 100 : 1134-1146, 1999

18 Hill JM, "Circulating endothelial progenitor cells, vascular function, and cardiovascular risk" 348 : 593-600, 2003

19 Porrello ER, "Building a new heart from old parts: stem cell turnover in the aging heart" 107 : 1292-1294, 2010

20 Okochi-Takada E, "ANGPTL4 is a secreted tumor suppressor that inhibits angiogenesis" 2013